Swainsonine: a new antineoplastic immunomodulator.
S Mohla, M J Humphries, S L White, K Matsumoto, S A Newton, C C Sampson, D Bowen, K Olden
Index: J. Natl. Med. Assoc. 81(10) , 1049-56, (1989)
Full Text: HTML
Abstract
Swainsonine, an indolizidine alkaloid with immunomodulatory activity, has been found to be effective in inhibiting metastatic dissemination and growth of primary tumors of both murine and human origins. The unique ability of swainsonine to exhibit antimetastatic, anti-proliferative, and immunomodulatory activity imparts this drug a promising future in cancer therapy.
Related Compounds
Related Articles:
2014-01-01
[Biotechnol. Prog. 30(5) , 1196-205, (2014)]
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.
2011-01-01
[Nucleic Acids Res. 39 , D1035-41., (2011)]
2012-12-01
[Oncol. Rep. 28(6) , 2091-100, (2012)]
Swainsonine as a lysosomal toxin affects dopaminergic neurons.
2012-12-01
[J. Neural Transm. Gen. Sect. 119(12) , 1483-90, (2012)]
2012-08-01
[J. Vet. Med. Sci. 74(8) , 989-93, (2012)]